VIRGINIA BENSINGER: Open Payments
NPI 1821342007 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,282 in 63 payments from 13 companies in 2025. Trend: 2023 $1,576 · 2024 $1,277 · 2025 $1,282
Food & beverage: $1,282
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $263 |
| Madrigal Pharmaceuticals | 7 | $226 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $117 |
| Lilly USA, LLC | 4 | $90 |
| Janssen Biotech, Inc. | 4 | $78 |
| Ipsen Biopharmaceuticals, Inc | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 7 | $69 |
| PFIZER INC. | 3 | $60 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
Products named: REZDIFFRA, ENTYVIO, LINZESS, XIFAXAN, OMVOH, TREMFYA, IQIRVO, VOQUEZNA.
Industry payments across AL — which companies pay providers there.
